Module 4: Medications - Resources

Further Reading

  1. Simmons S, Schleich A. Airway regional anesthesia for awake fiberoptic intubation. Reg Anesth Pain Med 2002;27(2):180-192.
  3. Chu KS, Wang FY et al. The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fiberoptic nasal intubation. EJA 2010;27:36-40.
  4. Scher CS, Gitlin MC. Dexmedetomidine and low-dose ketamine provide adequate sedation for awake fiberoptic intubation. CJA 2003;50(6):607-610.
  5. Abdelmalak B, Makary L et al. Dexmedetomidine as sole sedative for awake intubation in management of the critical airway. J Clin Anesth 2007;19:370-373.
  6. Dexmedetomidine Prescribing Summary Precedex®
  7. Woodall NM, Harwood RJ, Barker GL. Complications of awake fiberoptic intubation without sedation in 200 healthy anaesthetists attending a training course. BJA 2008;100(6):850-5.
  8. Woodall NM, Harwood RJ, Barker GL. Lidocaine toxicity in volunteer subjects undergoing awake fiberoptic intubation. Anesth Analg 2005;101(2):607.
  9. Rosenblatt WH. 59th Annual refresher course lecture notes. Paper presented at: Annual Meeting of the ASA; October 2008.
  10. Drummond JC. Airway anesthesia: the toothpaste method. CanJ Anaesth 2000;47:94.
  11. Chung DC, Mainland PA, Kong AS. Anesthesia of the airway by aspiration of lidocaine. CanJ Anaesth 1999;46:215-9.

Continue to: Module 5: Procedure